Search - tctmd.com

Displaying 21 - 40 of 1036

Sort: Relevancy | Date

Presentation THT 2026

Invasive exercise hemodynamics following transcatheter pulmonary artery banding (tPAB) for HFrEF.

Presenter: Marat Fudim

March 03, 2026

Presentation THT 2026

Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes after Interatrial Shunting in Heart Failure

Presenter: Jozef Bartunek

March 03, 2026

Presentation THT 2026

LVEF and Functional Improvement Observed in a Post-Market Registry of Barostim Baroreflex Activation Therapy

Presenter: Dmitry Yaranov

March 03, 2026

Presentation THT 2026

Real-World Outcomes of Barostim Baroreflex Activation Therapy in Heart Failure: Analysis of a Large Multi-Institutional Database.

Presenter: Arvind Bhimaraj

March 03, 2026

Presentation THT 2026

Impact of Pharmacist Virtual Consultation on GDMT Optimization in Hospitalized Patients

Presenter: Brad Williams

March 03, 2026

Presentation THT 2026

Supervised Learning vs. Foundation Models: A Comparative Appraisal of PanEcho and EchoPrime for Heart Failure Phenotyping

Presenter: Ahmad Nusairat

March 03, 2026

Presentation THT 2026

Real-World Comparison of Finerenone and Steroidal Mineralocorticoid Receptor Antagonists in Patients With Heart Failure With Reduced Ejection Fraction

Presenter: Thitiphan Srikulmontri

March 03, 2026

Presentation THT 2026

Early Interventions in Heart Failure Medications, Changes in Pulmonary Artery Pressure and Risk of Outcomes in Chronic Heart Failure Patients

Presenter: Sandip K. Zalawadiya

March 03, 2026

Presentation THT 2026

Comprehensive clinical benefit of CCM in HFrEF patients – a win-ratio analysis of FIX-HF-5C randomized trial

Presenter: Rami Kahwash

March 03, 2026

Presentation THT 2026

Results From The International MISSION Re-BEAT Feasibility Trial Using A Pulsatile, Soft Robotic Biventricular MCS Device That Avoids Blood Contact In Heart Failure Patients With Reduced Ejection Fraction

Presenter: Stephen Wildhirt

March 03, 2026

Presentation THT 2026

Early Human Feasibility Experience with a Novel Transcatheter Cardiac Leaflet Enhancer (CARLEN) to Treat Functional Mitral Regurgitation in Heart Failure reduced Ejection Fraction

Presenter: Edwin Ho

March 03, 2026

Presentation THT 2026

Atrial Shunt for Heart Failure with Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes from the REDUCE LAP-HF II Trial

Presenter: Sanjiv J. Shah

March 03, 2026

Presentation THT 2026

Left Atrial To Coronary Sinus Shunting In Heart Failure With Mildly Reduced Or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 3-Year Results

Presenter: Benjamin Hibbert

March 03, 2026

Presentation THT 2026

Predictors of Structural Remodeling After TAVR in Moderate Aortic Stenosis with Heart Failure with Reduced Ejection Fraction

Presenter: Afek Kodesh

March 03, 2026

Presentation THT Abstracts 2026

From Pressure Data to Clinical Impact: CardioMEMS in Heart Failure with Preserved Ejection Fraction Management

Presenter: Gabriella Bayshtok

March 02, 2026

Presentation THT 2026

Effect of Cardiac Contractility Modulation (CCM) Therapy on Reverse Remodeling in Heart Failure Patients with Left Ventricular Ejection Fraction 25-45%

Presenter: Rami Kahwash

March 02, 2026

Presentation THT Abstracts 2026

Baseline NT-proBNP Predicts Outcomes After Transcatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation with Preserved Ejection Fraction: The REPAIR Study

Presenter: Philipp von Stein

March 02, 2026

Presentation THT Abstracts 2026

Risk of Recurrence After Atrial Fibrillation Catheter Ablation in Heart Failure with Preserved Vs Reduced Ejection Fraction

Presenter: Nishanth Katukuri

March 02, 2026

Presentation THT 2026

Implant-Free Atrial Septal Shunt in a Heart Failure Patient with Reduced Ejection Fraction: A Case Report

Presenter: David Niehaus

March 02, 2026

News Features

Holding Out Hope for HF Shunts, Even After an FDA Panel’s Doubts

Michael O'Riordan

February 24, 2026

Advertisement

Invasive exercise hemodynamics following transcatheter pulmonary artery banding (tPAB) for HFrEF.

Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes after Interatrial Shunting in Heart Failure

LVEF and Functional Improvement Observed in a Post-Market Registry of Barostim Baroreflex Activation Therapy

Real-World Outcomes of Barostim Baroreflex Activation Therapy in Heart Failure: Analysis of a Large Multi-Institutional Database.

Impact of Pharmacist Virtual Consultation on GDMT Optimization in Hospitalized Patients

Supervised Learning vs. Foundation Models: A Comparative Appraisal of PanEcho and EchoPrime for Heart Failure Phenotyping

Real-World Comparison of Finerenone and Steroidal Mineralocorticoid Receptor Antagonists in Patients With Heart Failure With Reduced Ejection Fraction

Early Interventions in Heart Failure Medications, Changes in Pulmonary Artery Pressure and Risk of Outcomes in Chronic Heart Failure Patients

Comprehensive clinical benefit of CCM in HFrEF patients – a win-ratio analysis of FIX-HF-5C randomized trial

Results From The International MISSION Re-BEAT Feasibility Trial Using A Pulsatile, Soft Robotic Biventricular MCS Device That Avoids Blood Contact In Heart Failure Patients With Reduced Ejection Fraction

Early Human Feasibility Experience with a Novel Transcatheter Cardiac Leaflet Enhancer (CARLEN) to Treat Functional Mitral Regurgitation in Heart Failure reduced Ejection Fraction

Atrial Shunt for Heart Failure with Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes from the REDUCE LAP-HF II Trial

Left Atrial To Coronary Sinus Shunting In Heart Failure With Mildly Reduced Or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 3-Year Results

Predictors of Structural Remodeling After TAVR in Moderate Aortic Stenosis with Heart Failure with Reduced Ejection Fraction

From Pressure Data to Clinical Impact: CardioMEMS in Heart Failure with Preserved Ejection Fraction Management

Effect of Cardiac Contractility Modulation (CCM) Therapy on Reverse Remodeling in Heart Failure Patients with Left Ventricular Ejection Fraction 25-45%

Baseline NT-proBNP Predicts Outcomes After Transcatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation with Preserved Ejection Fraction: The REPAIR Study

Risk of Recurrence After Atrial Fibrillation Catheter Ablation in Heart Failure with Preserved Vs Reduced Ejection Fraction

Implant-Free Atrial Septal Shunt in a Heart Failure Patient with Reduced Ejection Fraction: A Case Report

Holding Out Hope for HF Shunts, Even After an FDA Panel’s Doubts

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content